380 related articles for article (PubMed ID: 19181251)
21. Physical optimization of afterloading techniques.
Anderson LL
Strahlentherapie; 1985 May; 161(5):264-9. PubMed ID: 4002251
[TBL] [Abstract][Full Text] [Related]
22. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
Fayed A; Mutch DG; Rader JS; Gibb RK; Powell MA; Wright JD; Elnaqa I; Zoberi I; Grigsby PW
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):480-4. PubMed ID: 17141980
[TBL] [Abstract][Full Text] [Related]
23. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.
Berger D; Dimopoulos J; Georg P; Georg D; Pötter R; Kirisits C
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1451-9. PubMed ID: 17289290
[TBL] [Abstract][Full Text] [Related]
24. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
[TBL] [Abstract][Full Text] [Related]
25. Optimization in high dose rate brachytherapy for utero-vaginal applications.
Cetingöz R; Ataman OU; Tuncel N; Sen M; Kinay M
Radiother Oncol; 2001 Jan; 58(1):31-6. PubMed ID: 11165679
[TBL] [Abstract][Full Text] [Related]
26. Optimized dose distribution of a high dose rate vaginal cylinder.
Li Z; Liu C; Palta JR
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):239-44. PubMed ID: 9588940
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric comparison of ring and ovoid applicators.
Tuncell N; Toy A; Demiral AN; Cetingoz R; Garipagaoglu M
J BUON; 2009; 14(3):451-5. PubMed ID: 19810138
[TBL] [Abstract][Full Text] [Related]
28. Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry.
Decker WE; Erickson B; Albano K; Gillin M
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):561-7. PubMed ID: 11380246
[TBL] [Abstract][Full Text] [Related]
29. Optimisation techniques in vaginal cuff brachytherapy.
Tuncel N; Garipagaoglu M; Kizildag AU; Andic F; Toy A
Br J Radiol; 2009 Nov; 82(983):936-40. PubMed ID: 19470571
[TBL] [Abstract][Full Text] [Related]
30. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
[TBL] [Abstract][Full Text] [Related]
31. Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society.
Harkenrider MM; Grover S; Erickson BA; Viswanathan AN; Small C; Kliethermes S; Small W
Brachytherapy; 2016; 15(1):23-9. PubMed ID: 26620818
[TBL] [Abstract][Full Text] [Related]
32. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
[TBL] [Abstract][Full Text] [Related]
33. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis.
Sapienza LG; Ning MS; Pellizzon ACA; Jhingran A; Klopp AH; Lin LL; Kollmeier MA; Calsavara VF; Gutierrez NDS; Chojniak R; Gomes MJL; Baiocchi G
Brachytherapy; 2019; 18(5):620-626. PubMed ID: 31160198
[TBL] [Abstract][Full Text] [Related]
34. Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk.
Glaser SM; Kim H; Beriwal S
Brachytherapy; 2015; 14(6):913-8. PubMed ID: 26412618
[TBL] [Abstract][Full Text] [Related]
35. Definition of vaginal doses in intrauterine high-dose-rate brachytherapy.
Nevelsky A; Bar-Deroma R; Cokal GY; Rosenblatt E; Kuten A
Brachytherapy; 2004; 3(2):101-5. PubMed ID: 15374542
[TBL] [Abstract][Full Text] [Related]
36. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators.
Beddar AS; Krishnan S; Briere TM; Wang X; Delclos ME; Ballo MT; Das P; Gould S; Horton JL; Crane CH
Radiother Oncol; 2006 Feb; 78(2):207-12. PubMed ID: 16376445
[TBL] [Abstract][Full Text] [Related]
37. Optimization and it's influence on value of doses in HDR and PDR brachytherapy.
Skowronek J; Zwierzchowski G; Piotrowski T; Milecki P
Neoplasma; 2010; 57(4):369-76. PubMed ID: 20429630
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
39. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer.
Chajon E; Dumas I; Touleimat M; Magné N; Coulot J; Verstraet R; Lefkopoulos D; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):955-61. PubMed ID: 17889277
[TBL] [Abstract][Full Text] [Related]
40. Evaluating adjacent organ radiation doses from postoperative intracavitary vaginal vault brachytherapy for endometrial cancer.
Caon J; Holloway C; Dubash R; Yuen C; Aquino-Parsons C
Brachytherapy; 2014; 13(1):94-9. PubMed ID: 24269147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
